Please disable your adblock and script blockers to view this page

3D-printing organs moves a few more steps closer to commercialization

Prellis Biologics
Volumetric Bio
Rice University
the University of Washington (UW
Duke University
Rowan University
Brown School of Engineering
Stanford University
Johns Hopkins
UC Irvine
Principal at Khosla Ventures

Melanie Matheu
Jordan Miller
Kelly Stevens
Volumetric Bio
Memorial Sloan Kettering
Alex Morgan


No matching tags

No matching tags

UC San Francisco

No matching tags

Positivity     32.00%   
   Negativity   68.00%
The New York Times
Write a review: TechCrunch

New successes in printing vascular tissue from living cells point to the accelerating pace of development of 3D printing tissue — and eventually the ability to manufacture organs from small samples of cells.Late last month Prellis Biologics announced a $8.7 million round of funding and some significant advancements that point the way forward for 3D printed organs while a company called Volumetric Bio based on research from a slew of different universities unveiled significant progress of its own earlier this year.The new successes from Prellis have the company speeding up its timeline to commercialization including the sale of its vascular tissue structures to research institutions and looking ahead to providing vascularized skin grafts, insulin producing sells, and a vascular shunt made from the tissue of patients who need dialysis, according to an interview with Melanie Matheu, Prellis’ chief executive officer and co-founder.The creation of a vascular shunt made from a patient’s own cells should increase the chances of the procedure working successfully, says Matheu.

As said here by Jonathan Shieber